AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
24.07.25
/
50%
€23.00
Target price
24.07.26
€67.94
Performance (%)
108.70%
Price
31.03.26
€48.20
Summary
This prediction is currently active. With a performance of 108.70% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 24.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | -10.741% | -10.741% |
| iShares Core DAX® | 0,75 % | -8,50 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % |
| iShares S&P 500 | -0,59 % | -2,87 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat